NCT03678883 2026-04-03
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
Actuate Therapeutics Inc.
Celgene
ETOP IBCSG Partners Foundation
Grupo Espanol de Investigacion en Sarcomas
NYU Langone Health
Novartis
University of Pittsburgh
GERCOR - Multidisciplinary Oncology Cooperative Group
Hellenic Oncology Research Group
Kaiser Permanente
Southeastern Gynecologic Oncology